A Population-based Study of the Association of Prostate-Specific Antigen Doubling Time (PSADT) with Metastasis-free Survival (MFS) and Overall Survival (OS) in Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) Patients (PTS) - Saad, F (J Urol, 2018)
PD10–04